Multi-Center Clinical Study Intensifies First Strike at High-Risk Cancer in Kids
- OPACC
- Jun 15, 2012
- 1 min read
An experimental treatment that combines intense chemotherapy with a radioactive isotope linked to synthesized neurotransmitter is being tested in newly diagnosed cases of high-risk neuroblastoma - a deadly, hard-to-cure childhood cancer.
Comments